Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Get Quote
Search InvestCenter
Recent Quotes
AZZ Inc.
Box, Inc. Class A Common Stock
Boyd Gaming Corporation Common Stock
Chegg, Inc. Common Stock
Covenant Logistics Group, Inc. - Class A Common Stock
Dick's Sporting Goods Inc Common Stock
Dycom Industries, Inc. Common Stock
Johnson & Johnson
Leidos Holdings, Inc. Common Stock
McDonald's Corp
McKesson Corp
Mission Produce, Inc. - Common Stock
SoundHound AI, Inc. - Class A Common Stock
Stratasys, Ltd. - Common Stock
Ulta Beauty, Inc. - Common Stock
Universal Logistics Holdings, Inc. - Common Stock
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
155.56
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
These S&P500 stocks are moving in today's pre-market session
April 01, 2025
Pre-market stock analysis of S&P500 stocks on 2025-04-01: top gainers and losers in today's session.
Via
Chartmill
J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan
April 01, 2025
The company says it will return to the civil court system to handle tens of thousands of claims its talc-based products caused cancer.
Via
Investor's Business Daily
Topics
Bankruptcy
Lawsuit
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
April 01, 2025
Johnson & Johnson will fight talc lawsuits in court after its subsidiary's bankruptcy plan was denied, reversing $7 billion in legal reserves.
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
April 01, 2025
From
Beasley Allen Law Firm
Via
Business Wire
2 Value Stocks I'm Buying Right Now
April 01, 2025
Via
The Motley Fool
Topics
Economy
Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
March 31, 2025
From
Johnson & Johnson
Via
Business Wire
Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
March 31, 2025
Value stocks are outperforming flashy growth rivals due to market uncertainty, making value-based ETFs a good bet for steady income and diversification.
Via
Benzinga
Topics
ETFs
Economy
1 Healthcare Stock to Target This Week and 2 to Turn Down
March 31, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...
Via
StockStory
Topics
Stocks
Is Hims & Hers Stock Too Cheap to Pass Up?
March 29, 2025
This high-growth stock may be cheaper than you think.
Via
The Motley Fool
3 Relatively Safe Stocks to Buy Right Now
March 29, 2025
Via
The Motley Fool
Topics
Intellectual Property
Elliott Wave Technical Analysis: Johnson & Johnson - Friday, March 28
March 28, 2025
Looking for further upside into wave {v}, as we appear to be missing one leg higher to complete the five-wave move subdivision.
Via
Talk Markets
Topics
Stocks / Equities
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
March 28, 2025
Via
The Motley Fool
Topics
ETFs
Economy
Government
2 Reasons to Like JNJ and 1 to Stay Skeptical
March 28, 2025
Since September 2024, Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.
Via
StockStory
Topics
Supply Chain
What Rare Earth Minerals Does Ukraine Have?
March 28, 2025
Ukraine is recognized as a country with significant mineral wealth, including a variety of rare earth elements (REEs) and other critical minerals. These resources have drawn global attention,...
Via
MarketMinute
Topics
Economy
Electric Vehicles
Emissions
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
March 27, 2025
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.
Via
Investor's Business Daily
Topics
Government
2 Recession-Proof Dividend Stocks to Buy and Hold
March 27, 2025
Via
The Motley Fool
J&J Drug Combo Outperforms Leading Lung Cancer Treatment In Survival Study
March 26, 2025
Johnson & Johnson's MARIPOSA study shows Rybrevant plus Lazcluze significantly extends overall survival in first-line EGFR-mutated NSCLC over osimertinib.
Via
Benzinga
Kenvue Stock In Focus As TOMS Capital Reportedly Pushes For Sale Or Breakup: Will It Shift Retail Mood?
March 24, 2025
Earlier this month, the company appointed three new directors, including Starboard Value CEO Jeffrey Smith, to its board as part of an agreement with the activist hedge fund after months of...
Via
Stocktwits
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness.
Via
Benzinga
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
March 21, 2025
Johnson & Johnson's Tremfya gains FDA approval for Crohn's disease, backed by Phase 3 trial data and demonstrating superiority over Stelara in key endpoints.
Via
Benzinga
Johnson & Johnson To Invest $55 Billion In US To Boost Manufacturing, Drug Discovery
March 21, 2025
Johnson & Johnson has announced a $55 billion investment in the U.S. over the next four years. This move will boost American manufacturing, research, and development, creating high-tech jobs and...
Via
Benzinga
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
March 21, 2025
From
Johnson & Johnson
Via
Business Wire
Two Sectors Just Tried And Failed - And That’s Great For Us
March 20, 2025
Technology and healthcare have both tried for a breakout and failed, courtesy of massive economic forces rocking the boat.
Via
Talk Markets
Topics
Stocks / Equities
Historic Dividend Outperformance
March 20, 2025
One of the most well-known dividend strategies is owning Dividend Aristocrats, of which the NOBL ETF tracks.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
March 20, 2025
JNJ stock hits Golden Cross, signaling potential long-term upside. Latest breakthrough in lung cancer treatment could provide additional catalyst.
Via
Benzinga
Honeywell Isn't Going to Let a Little Breakup Ruin Its Growth Plans
March 20, 2025
Via
The Motley Fool
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
March 18, 2025
HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.
Via
Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
March 18, 2025
Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results on disease activity and IgG reduction.
Via
Benzinga
Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
March 18, 2025
Nanobiotix amended its $2.7 billion licensing deal with Johnson & Johnson, reducing costs while retaining key milestone payments. The update extends its cash runway to mid-2026.
Via
Benzinga
Got $300? Buy These 3 Top Dividend Stocks and Never Look Back.
March 18, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.